VF
KPRX icon

Virtu Financial’s Kiora Pharmaceuticals KPRX Stock Holding History

Virtu Financial’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,134
Closed -$7K – 1611
2024
Q1 		$7K Sell
1,134
-2,026
-64% -$11.3K ﹤0.01% 1273
2023
Q4 		$15K Buy
+3,160
New +$16.4K ﹤0.01% 1363
2019
Q4 		$129K Buy
+36
New +$69.9K 0.01% 1031
2019
Q3 		– Sell
-3
Closed -$3K – 1635
2019
Q2 		$3K Sell
3
-11
-79% -$16.2K ﹤0.01% 1411
2019
Q1 		$23K Buy
14
+1
+8% +$2.43K ﹤0.01% 1274
2018
Q4 		$32K Buy
+13
New +$30K ﹤0.01% 1328
2018
Q1 		– Sell
-13
Closed -$77K – 2289
2017
Q4 		$77K Buy
13
+10
+333% +$61.9K ﹤0.01% 1985
2017
Q3 		$19K Buy
+3
New +$19.1K ﹤0.01% 2357

Other funds holding KPRX

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Virtu Financial's KPRX Position: Q2 2024 in Review

Virtu Financial sold out of Kiora Pharmaceuticals (KPRX) in Q2 2024, closing a stake of 1,134 shares — an estimated $7K sold.

Virtu Financial first reported a position in KPRX in Q3 2017 and held it in 8 quarters. The position peaked at $129K in Q4 2019. 17 funds tracked by Wall St. Rank hold KPRX as of Q2 2024.

  • Virtu Financial reported no remaining Kiora Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Virtu Financial sold 1,134 Kiora Pharmaceuticals shares in Q2 2024, an estimated $7K.
  • Virtu Financial first reported a position in Kiora Pharmaceuticals in Q3 2017 and held it in 8 quarters.
  • Virtu Financial's Kiora Pharmaceuticals position peaked at $129K in Q4 2019.
  • 17 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q2 2024.

Based on Virtu Financial's 13F filing for Q2 2024, filed 9 Aug 2024.